News
May 13, 2025NeuroOne Medical Technologies Corporation misses on earnings expectations. Reported EPS is $-72.98221 EPS, expectations were $-0.09. Operator: Good day, ladies and gentlemen. Welcome to ...
20m
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath©, a novel, FDA-cleared ...
Between 2022 and 2027, leading data and analytics company GlobalData forecasts show cybersecurity spending by healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback